Conversion Chemotherapy With a Modified FLOX Regimen for Borderline or Unresectable Liver Metastases From Colorectal Cancer: An Alternative for Limited-Resources Settings

PURPOSE: Conversion chemotherapy is often used for borderline or unresectable (B/U) liver metastases from colorectal cancer (CRC) with the aim of achieving resectability. Although intensive and costly regimens are often used, the best regimen in this scenario remains unclear. We aimed to evaluate th...

Full description

Bibliographic Details
Main Authors: Renata Colombo Bonadio, Paulo Henrique Amor Divino, Jorge Santiago Madero Obando, Karolina Cayres Alvino Lima, Débora Zachello Recchimuzzi, Jaime Arthur Pirola Kruger, Daniel Fernandes Saragiotto, Fernanda C. Capareli, Paulo M. Hoff
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-09-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.19.00180